Quarry LP Purchases Shares of 854 Select Medical Holdings Co. (NYSE:SEM)

Quarry LP bought a new stake in Select Medical Holdings Co. (NYSE:SEM) during the third quarter, according to its most recent disclosure with the SEC. The institutional investor bought 854 shares of the health services provider’s stock, valued at approximately $30,000.

A number of other hedge funds also recently made changes to their positions in the business. Point72 Asset Management L.P. increased its holdings in shares of Select Medical by 144.2% during the third quarter. Point72 Asset Management L.P. now owns 2,059,791 shares of the health services provider’s stock worth $71,825,000 after purchasing an additional 1,216,263 shares during the period. Millennium Management LLC grew its position in Select Medical by 183.9% during the second quarter. Millennium Management LLC now owns 679,522 shares of the health services provider’s stock worth $23,824,000 after buying an additional 440,140 shares in the last quarter. Hood River Capital Management LLC bought a new position in Select Medical during the 2nd quarter worth $14,819,000. Ceredex Value Advisors LLC acquired a new position in Select Medical in the 2nd quarter valued at $11,456,000. Finally, Loomis Sayles & Co. L P acquired a new stake in shares of Select Medical during the 3rd quarter worth $9,710,000. 89.48% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Select Medical

In other Select Medical news, VP Robert G. Breighner, Jr. sold 4,989 shares of the firm’s stock in a transaction on Wednesday, December 4th. The shares were sold at an average price of $19.95, for a total value of $99,530.55. Following the completion of the sale, the vice president now directly owns 30,356 shares in the company, valued at approximately $605,602.20. This trade represents a 14.12 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Marilyn B. Tavenner sold 32,000 shares of the company’s stock in a transaction dated Tuesday, November 26th. The shares were sold at an average price of $21.09, for a total transaction of $674,880.00. Following the transaction, the director now owns 22,000 shares in the company, valued at $463,980. This represents a 59.26 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 17.50% of the company’s stock.

Select Medical Trading Up 0.8 %

Shares of SEM stock opened at $19.83 on Friday. Select Medical Holdings Co. has a twelve month low of $19.52 and a twelve month high of $40.98. The stock’s fifty day simple moving average is $31.53 and its 200 day simple moving average is $33.85. The company has a quick ratio of 1.13, a current ratio of 1.13 and a debt-to-equity ratio of 1.37. The firm has a market capitalization of $2.57 billion, a P/E ratio of 9.27, a P/E/G ratio of 0.40 and a beta of 1.43.

Select Medical (NYSE:SEM) last issued its quarterly earnings data on Thursday, October 31st. The health services provider reported $0.43 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.36 by $0.07. The business had revenue of $1.76 billion during the quarter, compared to analyst estimates of $1.74 billion. Select Medical had a net margin of 3.97% and a return on equity of 15.99%. The firm’s quarterly revenue was up 5.7% on a year-over-year basis. During the same quarter last year, the business earned $0.46 EPS. As a group, sell-side analysts predict that Select Medical Holdings Co. will post 1.97 EPS for the current fiscal year.

Select Medical Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, November 26th. Shareholders of record on Wednesday, November 13th were issued a dividend of $0.125 per share. The ex-dividend date was Wednesday, November 13th. This represents a $0.50 annualized dividend and a yield of 2.52%. Select Medical’s payout ratio is 23.36%.

Wall Street Analysts Forecast Growth

Several research firms have commented on SEM. Benchmark lowered shares of Select Medical from a “buy” rating to a “hold” rating in a report on Monday, November 25th. StockNews.com upgraded Select Medical from a “hold” rating to a “buy” rating in a research note on Tuesday, December 3rd. Bank of America assumed coverage on Select Medical in a report on Tuesday, August 20th. They set a “buy” rating and a $42.00 price target for the company. Finally, Royal Bank of Canada lifted their target price on Select Medical from $40.00 to $47.00 and gave the company an “outperform” rating in a research report on Monday, November 4th.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.